louisiana glp-1 intestinal paralysis lawsuit Trulicity [2026] Ozempic GLP-1 Lawsuit & Gastroparesis

It is an unusual dynamic

Its active ingredient, semaglutide, is a GLP-1 (glucagon-like peptide-1) receptor agonist

This works well for patients who know what they need, though it does mean you need to be proactive about reaching out

[DOI] [PubMed] [Google Scholar] 97.Vanderheyden M, Bartunek J, Goethals M, Verstreken S, Lambeir AM, De Meester I, et al

In one of the clinical trials, 13 patients taking canagliflozin suffered a major cardiovascular event (including heart attacks and strokes) within the first 30 days of taking the drug, compared with 1 patient taking a placebo

Since KD naturally reduces hunger and drives energy deficits without calorie counting, it offers similar or greater weight-loss benefits as appetite-suppressing drugs or those that block fat absorption without documented adverse effects such as nausea and diarrhea